目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T2547 | Adrenergic Receptor | ||
Droxidopa (L-DOPS) 是 Droxidopa (w/w80%) 和 Pharmaceutical starch (w/w20%) 的混合物,能透过血脑屏障,可作为神经递质去甲肾上腺素和肾上腺素的原药。 | |||
T32737 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Liafensine(BMS-820836) 是一种新型且具有选择性的三重单胺再摄取抑制剂,对血清素、去甲肾上腺素和多巴胺的再摄取具有抑制作用,可用于研究重度抑郁症和中枢神经系统疾病。 | |||
T10358 | ROCK | ||
Netarsudil Dihydrochloride (AR-13324 Dihydrochloride) 是 Rho 相关蛋白激酶 (ROCK) 和去甲肾上腺素转运蛋白 (NET) 的抑制剂,可有效降低眼压 (IOP)。 | |||
T2594 | Serotonin Transporter Norepinephrine | ||
Dextromilnacipran (Levomilnacipran) 是米那普仑的对映体,是一种选择性 5- 羟色胺和去甲肾上腺素(5-HT/NE)再摄取抑制剂,也是一种人类 α 肾上腺素能受体拮抗剂,IC50=3.4 μM。 | |||
T0973L | Nrf2 Endogenous Metabolite | ||
Pyridoxine hydrochloride (Vitamin B6) 是一种吡啶衍生物。在于阿尔茨海默病细胞模型中,通过 Nrf-2/HO-1 途径发挥抗氧化作用。 | |||
T13110 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Tedatioxetine hydrobromide (Lu AA 24530 hydrobromide) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂 ,也是 5-HT2A、5-HT2C、5-HT3 和 α1A-肾上腺素能受体的拮抗剂,可用于治疗抑郁症和焦虑症。 | |||
T71746 | Others | ||
Pincainide 是一种新型β-氨基苯胺,以剂量依赖的方式抑制去甲肾上腺素血管平滑肌功能异常引起的疾病。 | |||
T7941 | Serotonin Transporter | ||
Imipramine hydrochloride (Imipramine HCl) 可抑制血清素转运蛋白,IC50=32 nM。它可阻止胰酶的易位,阻碍 MV 和外泌体的分泌。 | |||
TQ0135 | Endogenous Metabolite | ||
3,4-Dihydroxymandelic acid 是一种去甲肾上腺素的代谢产物,存在于所有生物体中。 | |||
T5954 | Dopamine Receptor Adrenergic Receptor | ||
Methyldopa hydrate (MK-351 hydrate) 是一种前药,在中枢神经系统中被代谢成 α-Methylepinephrine。它是一种 α-肾上腺素能激动剂,对α2-adrenergic receptors 有选择性。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-03852 | Dopamine beta-Hydroxylase Protein, Human, Recombinant (His) | Human | HEK293 Cells | ||
DBH is a 29 kDa copper-containing oxygenase. It can be detected in noradrenergic nerve terminals of the central and peripheral nervous systems, and is also expressed in chromaffin cells of the adrenal medulla. DBH contains our identical subunits, and its activity requires ascorbate as a cofactor. It functions in in the synthesis of small-molecule neurotransmitters that is membrane-bound, making norepinephrine the only transmitter synthesized inside vesicles. DBH has been shown to be associated with decision making and addictive behaviors such as alcohol and smoking, attention deficit hyperactivity disorder, and also with neurological diseases such as Schizophrenia and Alzheimer's.
|
|||||
TMPY-02948 | SULT1A3 Protein, Human, Recombinant (His) | Human | E. coli | ||
SULT1A3 belongs to the sulfotransferase 1 family. Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. They are different in their tissue distributions and substrate specificities while their gene structure (number and length of exons) is similar. SULT1A3 gene encodes a phenol sulfotransferase with thermolabile enzyme activity. Four sulfotransferase genes are located on the p arm of chromosome 16; this gene and SULT1A4 arose from a segmental duplication. It is the most centromeric of the four sulfotransferase genes. Exons of this gene overlap with exons of a gene that encodes a protein containing GIY-YIG domains (GIYD1). SULT1A3 is expressed in liver, colon, kidney, lung, brain, spleen, small intestine, placenta and leukocyte. SULT1A3 is a sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, norepinephrine and serotonin) and phenolic and catechol drugs.
|